Company search
Overview
Performance
Portfolio
ESG
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Portfolio yield
Data as at : 30/06/2026
| % |
|---|
| 0.1 |
Please note that the above fields are displayed for companies that have reported this data to the AIC. Where data is reported, it may be subject to valuation lags.
Top holdings
Data as at : 30/04/2026
| Investment | % of total assets |
|---|---|
| Other Assets And Liabilities | 23.3 |
| UroGen Pharma Ltd | 3.7 |
| Xenon Pharmaceuticals Inc | 3.5 |
| Rhythm Pharmaceuticals Inc | 3.3 |
| Praxis Precision Medicines Inc Ordinary Shares | 3.2 |
| Revolution Medicines Inc Ordinary Shares | 3.2 |
| Biogen Inc | 3.1 |
| Kiniksa Pharmaceuticals International PLC Class A | 3.1 |
| Cogent Biosciences Inc | 3.0 |
| Relmada Therapeutics Inc | 3.0 |
Geographic breakdown
Data as at : 30/06/2026
| Country | % of total assets |
|---|---|
| USA | 84.0 |
| Netherlands | 6.0 |
| Canada | 5.6 |
| China | 4.9 |
| UK | 2.5 |
| Denmark | 2.0 |
| Taiwan | 0.6 |
| France | 0.4 |
| Belgium | 0.3 |
Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.
Industry breakdown
Data as at : 30/06/2026
| Industry | % of total assets |
|---|---|
| Healthcare | 101.5 |
| Industrials | 0.2 |
| Cash Equivalents | -37.6 |
Scroll
Asset breakdown
Data as at : 30/06/2026
| Asset | % of total assets |
|---|---|
| Stock | 107.0 |
| Other | 30.6 |
| Cash/Cash equivalents | -37.6 |
Detailed asset breakdown
Data as at : 30/06/2026
| Asset | % of total assets |
|---|---|
| North America - stock | 92.5 |
| Other | 30.6 |
| Other - stock | 5.7 |
| Asia (excl Japan) - stock | 3.8 |
| Europe - Mid-cap stock | 3.3 |
| Europe - Small-cap stock | 1.6 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
